Opinion

Alternatives to GLP-1 medications

As plan sponsors consider the costs and efficacy of GLP-1 drugs, they should not ignore alternatives

Alternatives to GLP-1 medications

Get ready for a new era of deal-making

The next M&A cycle will be more complex. Here's why

Get ready for a new era of deal-making

Liquidity issues affecting private markets

A multi-manager, multi-strategy approach to private markets investing can optimize for returns, volatility and liquidity

Liquidity issues affecting private markets

Navigating ESG's evolution

ESG has hit the mainstream, but what happens next is crucial

Navigating ESG's evolution

Fertility and family planning benefits

How an employer's perspective on and handling of fertility and family-planning benefits can help or hinder workplace culture

Fertility and family planning benefits

Farmland as a Portfolio Enhancer

This less-known asset class offers a range of promising characteristics that can help pension funds navigate a challenging macro environment

Farmland as a Portfolio Enhancer